The American Society for Pharmacy Law (ASPL) is an organization of attorneys, pharmacists, pharmacist-attorneys and students of pharmacy or law who are interested in the law as it applies to
pharmacy, pharmacists, wholesalers, manufacturers, state and federal government and other interested parties.

ASPL is a non-profit which encourages diversity & inclusion with the Society, regardless of differing backgrounds, perspectives, experiences, orientations, origins, and practice settings. The Society embraces participation and diversity as it leads to advancing our purpose: 

  • Furthering knowledge in the law related to pharmacists, pharmacies, the provision of pharmaceutical care, the manufacturing and distribution of drugs, and other food, drug, and medical device policy issues;
  • Communicating accurate legal educational information; and
  • Providing educational opportunities for pharmacists, attorneys, and others who are interested in pharmacy law

Latest News

June 27, 2022

ABORTION
Attorney General Garland opines that states cannot ban FDA-approved abortifacients
On June 24, US Attorney General Merrick Garland issued a statement regarding Dobbs v. Jackson Women’s Health Organization, 590 U.S. ___ 2022, in which he noted that “The Justice Department strongly disagrees with the Court’s decision.” He noted, however, that “today’s decision does not eliminate the ability of states to keep abortion legal within their borders. And the Constitution continues to restrict states’ authority to ban reproductive services provided outside their borders.”

Garland asserted that the Justice Department will not tolerate violence and threats of violence arising from the debate over abortion rights, and “will work tirelessly to protect and advance reproductive freedom.” Garland opined that “the FDA has approved the use of the medication Mifepristone. States may not ban Mifepristone based on disagreement with the FDA’s expert judgment about its safety and efficacy.”

He stated that the Justice Department will continue to hold that “States may not impose criminal or civil liability on federal employees who perform their duties in a manner authorized by federal law.” [USDOJ, News. Attorney General Merrick B. Garland statement on Supreme Court ruling in Dobbs v. Jackson Women’s Health Organization, 2022 Jun 24; https://bit.ly/3OrmsiE]

In wake of Dobbs, demand for contraceptives and mifepristone increases
On June 26, the New York Times reported that concerned patients – and parents – have been stocking up on contraceptives such as Plan B®, and the demand for medical abortions using mifepristone and misoprostol has surged. In 2020, over 50% of all abortions undertaken in the US were medical, rather than surgical, abortions, and post-Dobbs,  the percentage is expected to continue to rise. One telemedicine abortion provider, Hey Jane, reported a 10-fold increase in traffic on its website. [Holpuch A. As states ban abortion, demand for birth control and abortion pills is rising. New York Times, 2022 Jun 26; https://nyti.ms/39RWnu9]